Core Viewpoint - The establishment of the "Xiamen Nest and Nest Peptide Quality Control and Health Efficacy Application Joint Laboratory" marks a significant collaboration among Xiamen Customs Technology Center, Fujian Agriculture and Forestry University, and Yan Zhi Wu, aimed at enhancing the quality and health efficacy of the nest industry through technological innovation [2][3]. Group 1 - The joint laboratory aims to address core issues in the nest industry, such as authenticity verification, quality standards, and efficacy validation, driven by the increasing consumer demand for health products [2][3]. - The collaboration leverages the strengths of government, academia, and industry to overcome technical bottlenecks in quality control and explore the health efficacy mechanisms of nests and nest peptides [2][3][5]. - The laboratory's goals include establishing a reliable quality control system, investigating the scientific mechanisms of health efficacy, and accelerating the industrialization of research outcomes [3][5]. Group 2 - The partnership signifies a new phase of deep integration between industry, academia, and research, enhancing the global competitiveness of the Xiamen nest industry [3]. - Yan Zhi Wu, with 27 years of focus on high-quality nests, aims to lead the industry towards standardization and technological advancement, becoming the first listed company in China's nest industry [2][5]. - The joint laboratory is envisioned as an efficient platform for research breakthroughs, technological innovation, outcome transformation, and talent cultivation in the nest industry [5].

Core Viewpoint - Yan Zhi Wu has received the "world's first patent authorization for the efficacy and application of bird's nest peptides," marking a significant advancement in the industry and establishing a benchmark for scientific validation and industrial transformation [1][11]. Group 1: Patent and Technology - The patent granted to Yan Zhi Wu is for a method of preparing bird's nest peptides that promote cell repair and provide high moisturizing and whitening effects (Patent No: ZL 2022 11398048.3) [1][4]. - The patented technology clarifies the enzymatic hydrolysis process of bird's nest peptides, revealing their properties such as moisturizing, whitening, and antioxidant effects, thus overcoming the industry's previous limitations of vague components and effects [3][4]. - The enzymatic hydrolysis process involves precise control to produce small molecular peptides with an average molecular weight of less than 1000 Da, enhancing the bioavailability of active ingredients [3][4]. Group 2: Research and Development - Yan Zhi Wu established a bird's nest peptide research center in January 2022, focusing on enzymatic technology, active ingredient research, and product development, achieving significant breakthroughs published in international journals [4]. - The company has received multiple industry awards, including the "Bird's Nest Peptide - Industry Innovation Award" in 2023, recognizing its contributions to the development of the bird's nest industry [4][5]. - In 2024, Yan Zhi Wu's bird's nest peptides were awarded the "Top 10 Chinese Innovative Raw Materials" and "Chinese Ace Ingredient Award," further solidifying its leadership in the field [4][8]. Group 3: Product Development - In 2022, Yan Zhi Wu launched its skincare brand "YAN PALACE," featuring small molecular bird's nest peptides as core ingredients, developing products like multi-effect facial masks and essence [8]. - The company was recognized by Frost & Sullivan as the "pioneer of bird's nest peptide skincare products" based on comparative research of Chinese skincare products [8][11]. - Yan Zhi Wu aims to provide healthier skincare experiences for women, promoting the concept of "bird's nest peptides advocating a new skin ecology" [8][9].